is dizziness a symptom of tirzepatide Does Cause Flu-Like Symptoms? What Patients Should Know Tirzepatide (Zepbound) for weight loss

According to the International Diabetes Federation[1], every year over 589 million adults worldwide grapple with diabetes, a number projected to soar past 850 million by 2050, making diabetes and obesity among the most urgent global health crises of our time

GLP-1s are renowned for their effectiveness in reducing appetite and enhancing fat loss, making them a cornerstone of our medical weight management solutions.

Findings from the SURPASS-AP-Combo trial demonstrate that addition of tirzepatide is non-inferior and superior to insulin glargine for glycemic outcomes at 40weeks when used as second-line or third-line therapy in an Asia-Pacific (predominantly Chinese) population with type 2 diabetes.

Today,wereproud to announce a new partnership withPhlo, the industry-leading provider of digital health services, bringingclinically-ledweight management support to customers across our stores and online - supporting a moreholistic approachto weight management Heres what this means: Phlos clinical weight management services will be signposted in-store and online Customers can easily access these services viahollandandbarrett.comand in-store QR codes Phlo will deliver all clinical services, including assessment, prescribing and ongoing support Holland & Barrett will connect customers to these services while continuing to support them with trusted nutrition, wellness products and in-store expertise Leila Thabet, Director of Wellness Platform at Holland & Barrett, said: We know that weight management is deeply personal and that the right support can look different for everyone

Learn how this investigational triple agonist works, its safety considerations, UK regulatory status, and when to speak to your diabetes team.

In a study published in the journal JAMA Internal Medicine, r